A new Des Moines company is expected to become Iowa’s first legal producer of medical marijuana products.
The Iowa Department of Public Health announced Tuesday that it intends to issue a license to MedPharm Iowa, which would produce medications derived from cannabis plants. Department spokeswoman Polly Carver-Kimm said MedPharm’s permit is expected to be the sole production license the state issues under a new law allowing production and distribution of medical marijuana products in Iowa.
MedPharm Iowa is owned by Chris Nelson, who is the president of Kemin Industries. Kemin is a large company producing food ingredients and supplements that it ships around the world.
“With the creation of MedPharm Iowa, we will use our innovative expertise and experience with scientifically sound research to assist those dealing with chronic pain, cancer, debilitating diseases and possibly help alleviate the opioid epidemic in Iowa,” Nelson said in a news release. The company plans to set up a production and manufacturing facility for medical cannabis products at Kemin’s campus south of downtown Des Moines. Under the state law, it must start providing products by Dec. 1, 2018.
The health department later would approve permits for distributors of the products MedPharm Iowa makes. The new company is associated with MedPharm Colorado, which specializes in such products. [Read more at Des Moines Register]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
The process was like the slow burn of a fatty (prescribed for medicinal use only, of course). Last week, five years after Floridians voted to legalize medical marijuana in 2016, state officials announced an “emergency rule” that sets aside one medical marijuana license specifically for a Black farmer. That might seem like a welcome measure to help…
The federal farm bill in 2018 made the substance legal because of its low THC content. Three years after federal legislation removed the marijuana extract known as delta-8 THC from the nation’s list of controlled substances, Texas health officials have put it on its own list of illegal drugs, sending a shockwave through the growing…
The FDA’s failure to regulate a multibillion-dollar market is a detriment to consumers and businesses alike. In August of last year, the Food and Drug Administration held a teleconference with Sarah Brown, the proprietor of Maison Terre, a natural products repackager that Brown ran out of her home in Arkansas. An FDA lab analysis had…
In my 40 years of collecting a paycheck, I gotta admit this has been the oddest business trip I have ever embarked on, beginning with the packed Spirit Airline flight from Baltimore-Washington International Airport to the check-in at the Westgate hotel to grabbing my press credentials Tuesday afternoon at the Las Vegas Convention Center. When…